Tag: Clinical Trials

investimento

Eli Lilly Stock Soars or Dives? Shocking Q2 Trial Results Hang in the Balance!

Marcel Trisent 02/15/2025

Miracle Treatment Unveiled: Could This Company Be the Key to Defeating Alopecia Areata?

Miracle Treatment Unveiled: Could This Company Be the Key to Defeating Alopecia Areata?

Leonardo Martins 02/05/2025

Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA By Investing.com

Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA By Investing.com

Leonardo Martins 01/27/2025

Get Curated Post Updates!

Sign up for my newsletter to see new photos, tips, and blog posts.